Advances in Itch: Brian S. Kim, MD, Shares Insights and Treatment Tips
Kim, who received the Marion B. Sulzberger Award at the 2024 American Academy of Dermatology Annual Meeting, discussed itch research an implications for clinical practice.
Nuogen Pharma: Innovation in the fight against itch
Nuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.
The Weekly Roundup: June 30-July 3
Dermatology Times Spot Test: July 3, 2025
The Future of Exoceuticals and Innovative Aesthetics, According to Robin Smith, MD, MBA
New Data Support Delgocitinib for Sensitive Skin Areas